Company intelligence / Profile preview

Trukera Medical

Southlake, Texas, United Statestrukera.com ↗

Ownership: Private
Employees: ~263
Development stage: Commercial

Overview

The company’s osmolarity testing systems are FDA-cleared and CE-marked point-of-care devices for measuring tear osmolarity. Over 24 million tests have been performed worldwide. These diagnostics are considered essential for dry eye and corneal health assessment in clinical practice.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Metabolite Diagnostics

Drug pipeline

2 assets

TearLab Osmolarity System

Commercial

Indications: Dry eye disease

1 more asset in the full pipeline.

Request access →

Partnerships

Bausch + Lomb Corp.

Beyond the preview

Go deeper on Trukera Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trukera Medical.

Explore the full profile